AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.89%33.450.9%$1134.85m
JNJJohnson & Johnson -0.59%142.420.7%$1072.66m
BMYBristol-Myers Squibb Co. -2.42%58.121.0%$943.99m
MRKMerck & Co., Inc. -1.57%76.700.7%$803.90m
ABBVAbbVie, Inc. -1.29%98.002.3%$774.89m
LLYEli Lilly & Co. -1.60%166.421.1%$684.88m
AZNAstraZeneca Plc -0.39%53.981.2%$288.95m
VXRTVaxart, Inc. 0.49%8.190.0%$287.88m
RPRXRoyalty Pharma Plc 0.71%48.360.1%$228.11m
NVSNovartis AG -0.86%87.360.2%$150.20m
RGENRepligen Corp. 2.71%128.677.2%$120.40m
GSKGlaxoSmithKline Plc -0.96%40.340.2%$111.37m
NVONovo Nordisk A/S -0.43%65.600.1%$93.80m
RETAReata Pharmaceuticals, Inc. -1.19%156.123.4%$81.15m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -2.71%75.840.0%$71.31m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.